Adult Giant Cell Glioblastoma

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00853	Temozolomide	0	Active Not Recruiting	1
DB08885	Aflibercept	1	Completed	1
DB05220	Alisertib	1	Active Not Recruiting	1
DB00855	Aminolevulinic acid	1	Terminated	1
DB01169	Arsenic trioxide	1	Completed	1
DB11851	Bafetinib	1	Completed	1
DB00188	Bortezomib	1	Terminated	1
DB04849	Cediranib	1	Completed	2
DB11890	Cilengitide	1	Completed	1
DB11890	Cilengitide	1	Terminated	1
DB08908	Dimethyl fumarate	1	Completed	1
DB00530	Erlotinib	1	Completed	1
DB00530	Erlotinib	1	Terminated	1
DB01099	Flucytosine	1	Active Not Recruiting	1
DB01099	Flucytosine	1	Completed	1
DB00762	Irinotecan	1	Recruiting	1
DB00762	Irinotecan	1	Withdrawn	1
DB00982	Isotretinoin	1	Terminated	1
DB00160	L-Alanine	1	Terminated	1
DB01259	Lapatinib	1	Recruiting	1
DB00650	Leucovorin	1	Active Not Recruiting	1
DB00134	Methionine	1	Completed	1
DB11870	RG-4733	1	Completed	2
DB11870	RG-4733	1	Terminated	1
DB00398	Sorafenib	1	Completed	1
DB00853	Temozolomide	1	Active Not Recruiting	1
DB00853	Temozolomide	1	Completed	6
DB06287	Temsirolimus	1	Completed	1
DB04960	Tipifarnib	1	Completed	2
DB00755	Tretinoin	1	Terminated	1
DB02546	Vorinostat	1	Active Not Recruiting	1
DB02546	Vorinostat	1	Terminated	1
DB05428	motexafin gadolinium	1	Completed	1
DB00112	Bevacizumab	1 / 2	Completed	1
DB00112	Bevacizumab	1 / 2	Terminated	1
DB04849	Cediranib	1 / 2	Completed	1
DB11890	Cilengitide	1 / 2	Completed	1
DB00530	Erlotinib	1 / 2	Completed	2
DB00530	Erlotinib	1 / 2	Unknown Status	1
DB09150	Fludeoxyglucose F-18	1 / 2	Active Not Recruiting	1
DB09502	Fludeoxyglucose F-18	1 / 2	Active Not Recruiting	1
DB00317	Gefitinib	1 / 2	Completed	1
DB04845	Ixabepilone	1 / 2	Completed	1
DB00134	Methionine	1 / 2	Completed	1
DB00526	Oxaliplatin	1 / 2	Terminated	1
DB06641	Perifosine	1 / 2	Terminated	1
DB06809	Plerixafor	1 / 2	Completed	1
DB11870	RG-4733	1 / 2	Terminated	1
DB06176	Romidepsin	1 / 2	Completed	1
DB00398	Sorafenib	1 / 2	Completed	2
DB05465	Tandutinib	1 / 2	Completed	1
DB00853	Temozolomide	1 / 2	Active Not Recruiting	1
DB00853	Temozolomide	1 / 2	Completed	4
DB06287	Temsirolimus	1 / 2	Completed	3
DB06287	Temsirolimus	1 / 2	Terminated	1
DB04960	Tipifarnib	1 / 2	Completed	1
DB02546	Vorinostat	1 / 2	Active Not Recruiting	1
DB05428	motexafin gadolinium	1 / 2	Completed	1
DB08885	Aflibercept	2	Completed	1
DB00855	Aminolevulinic acid	2	Terminated	1
DB06769	Bendamustine	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Active Not Recruiting	3
DB00112	Bevacizumab	2	Recruiting	1
DB00188	Bortezomib	2	Completed	1
DB11960	Carboxyamidotriazole	2	Completed	1
DB04849	Cediranib	2	Completed	1
DB11890	Cilengitide	2	Completed	1
DB01254	Dasatinib	2	Completed	1
DB05928	Dovitinib	2	Completed	1
DB00530	Erlotinib	2	Completed	2
DB05076	Fenretinide	2	Terminated	1
DB00317	Gefitinib	2	Completed	1
DB05707	Isosorbide	2	Completed	1
DB00160	L-Alanine	2	Terminated	1
DB06589	Pazopanib	2	Completed	1
DB11870	RG-4733	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Completed	1
DB01268	Sunitinib	2	Completed	1
DB00853	Temozolomide	2	Active Not Recruiting	2
DB00853	Temozolomide	2	Completed	1
DB00853	Temozolomide	2	Recruiting	1
DB06287	Temsirolimus	2	Completed	1
DB04960	Tipifarnib	2	Completed	1
DB12056	Trebananib	2	Active Not Recruiting	1
DB08828	Vismodegib	2	Completed	1
DB02546	Vorinostat	2	Completed	2
DB00112	Bevacizumab	3	Completed	1
DB00853	Temozolomide	3	Completed	1
DB12736	Etanidazole	Not Available	Terminated	1
DB00743	Gadobenic acid	Not Available	Terminated	1
DB06703	Gadobutrol	Not Available	Terminated	1
DB00789	Gadopentetic acid	Not Available	Terminated	1